Outcomes of pregnancy in women with different types of pulmonary hypertension.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
09 08 2023
Historique:
received: 19 03 2023
accepted: 01 08 2023
medline: 11 8 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: epublish

Résumé

Pulmonary hypertension (PH) is considered to increase maternal and fetal risk, and we attempt to explore pregnancy outcomes in women with different types of PH. We retrospectively analyzed the clinical data of pregnant women with PH who were admitted to Anzhen Hospital from January 2010 to December 2019, and followed up on these parturients and their offspring. Three hundred and sixty-six pregnant women with PH were collected, including 265 pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD), 65 PH caused by left heart disease, 12 idiopathic PH, and 24 PH associated with other diseases. Maternal mean age was 28.4 ± 4.4 years and 72.1% were nulliparous. The estimated systolic pulmonary artery pressure was < 50 mmHg in 40.2% of patients, 50-70 mmHg in 23.2%, and > 70 mmHg in 36.6%. In more than 94% of women, a diagnosis of PH was made before pregnancy. During pregnancy, heart failure occurred in 15% of patients. Cesarean section was performed in 90.5% (20.4% emergency). Complications included fetal mortality (0.5%), preterm delivery (40.4%), and low birth weight (37.7%). A total of 20 mothers died (5.5%). The highest mortality rate was found in patients with idiopathic PH (4/12, 33.3%). A total of 12 children died (3.3%), 5 (1.4%) of them after discharge from the hospital, and 7 (1.9%) were in hospital. Although most of these women are fertile, PH does increase maternal and fetal risk. Women with idiopathic PH and Eisenmenger syndrome are not recommended to have children.

Sections du résumé

BACKGROUND
Pulmonary hypertension (PH) is considered to increase maternal and fetal risk, and we attempt to explore pregnancy outcomes in women with different types of PH.
METHODS
We retrospectively analyzed the clinical data of pregnant women with PH who were admitted to Anzhen Hospital from January 2010 to December 2019, and followed up on these parturients and their offspring.
RESULTS
Three hundred and sixty-six pregnant women with PH were collected, including 265 pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD), 65 PH caused by left heart disease, 12 idiopathic PH, and 24 PH associated with other diseases. Maternal mean age was 28.4 ± 4.4 years and 72.1% were nulliparous. The estimated systolic pulmonary artery pressure was < 50 mmHg in 40.2% of patients, 50-70 mmHg in 23.2%, and > 70 mmHg in 36.6%. In more than 94% of women, a diagnosis of PH was made before pregnancy. During pregnancy, heart failure occurred in 15% of patients. Cesarean section was performed in 90.5% (20.4% emergency). Complications included fetal mortality (0.5%), preterm delivery (40.4%), and low birth weight (37.7%). A total of 20 mothers died (5.5%). The highest mortality rate was found in patients with idiopathic PH (4/12, 33.3%). A total of 12 children died (3.3%), 5 (1.4%) of them after discharge from the hospital, and 7 (1.9%) were in hospital.
CONCLUSIONS
Although most of these women are fertile, PH does increase maternal and fetal risk. Women with idiopathic PH and Eisenmenger syndrome are not recommended to have children.

Identifiants

pubmed: 37558980
doi: 10.1186/s12872-023-03423-4
pii: 10.1186/s12872-023-03423-4
pmc: PMC10410774
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

391

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

van Hagen IM, Roos-Hesselink JW. Pregnancy in congenital heart disease: risk prediction and counselling. Heart. 2020;106(23):1853–61.
doi: 10.1136/heartjnl-2019-314702 pubmed: 32611675
Sliwa K, van Hagen IM, Budts W, et al. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail. 2016;18(9):1119–28.
doi: 10.1002/ejhf.594 pubmed: 27384461
Martin SR, Edwards A. Pulmonary Hypertension and Pregnancy. Obstet Gynecol. 2019;134(5):974–87.
doi: 10.1097/AOG.0000000000003549 pubmed: 31599832
Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.
doi: 10.1183/13993003.01913-2018 pubmed: 30545968 pmcid: 6351336
Gei A, Montufar-Rueda C. Pulmonary Hypertension and Pregnancy: An Overview. Clin Obstet Gynecol. 2014;57(4):806–26.
doi: 10.1097/GRF.0000000000000076 pubmed: 25314091
Olsson KM, Channick R. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev. 2016;25:431–7.
doi: 10.1183/16000617.0079-2016 pubmed: 27903665 pmcid: 9487551
Meng M-L, Landau R, Viktorsdottir O, et al. Pulmonary Hypertension in Pregnancy, A Report of 49 Cases at Four Tertiary North American Sites. Obstet Gynecol. 2017;129(3):511–20.
doi: 10.1097/AOG.0000000000001896 pubmed: 28178055
Shujaat A, Bajwa AA, Al-Saffar F, Bellardini J, Jones L, Cury JD. Diagnostic accuracy of echocardiography combined with chest CT in pulmonary hypertension. Clin Respir J. 2018;12(3):948–52.
doi: 10.1111/crj.12610 pubmed: 28063199
Hoeper MM, Humbert M, Souza R, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4(4):306–22.
doi: 10.1016/S2213-2600(15)00543-3 pubmed: 26975810
Li Q, Zhang C, Wang R, Keller BB, Gu H. Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization. Pulm Circ. 2022;12(2):e12067.
doi: 10.1002/pul2.12067 pubmed: 35514786 pmcid: 9063957
Zhu Y, Jiang Qi, Zhang W, Renjie Hu, Dong W, Zhang H, Zhang H. Outcomes and occurrence of post-operative pulmonary hypertension crisis after late referral truncus arteriosus repair. Front Cardiovasc Med. 2022;27(9):999032.
doi: 10.3389/fcvm.2022.999032
Zhang J, Jiakai Lu, Zhou X, et al. Perioperative management of pregnant women with idiopathic pulmonary arterial hypertension: an observational case series study from China. J Cardiothorac Vasc Anesth. 2018;32(6):2547–59.
doi: 10.1053/j.jvca.2018.01.043 pubmed: 29525197
Sadeghi S, Granton JT, Akhavan P, et al. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension. Respirology. 2015;20(3):481–7.
doi: 10.1111/resp.12464 pubmed: 25583377
Ladouceur M, Benoit L, Radojevic J, et al. Pregnancy outcomes in patients with pulmonary arterial hypertension associated with congenital heart disease. Heart. 2017;103:287–92.
doi: 10.1136/heartjnl-2016-310003 pubmed: 27511447
Li Q, Dimopoulos K, Liu T, et al. Peripartum outcomes in a large population of women with pulmonary arterial hypertension associated with congenital heart disease. Eur J Prev Cardiol. 2019;26(10):1067–76.
doi: 10.1177/2047487318821246 pubmed: 30971116
Duan R, Xiumei Xu, Wang X, et al. Pregnancy outcome in women with Eisenmenger’s syndrome: a case series from west China. BMC Pregnancy Childbirth. 2016;16(1):356.
doi: 10.1186/s12884-016-1153-z pubmed: 27852228 pmcid: 5112756
Kempny A, Hjortshøj CS, Gu H, et al. Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicenter study. Circulation. 2017;135(15):1432–40.
doi: 10.1161/CIRCULATIONAHA.116.023033 pubmed: 27979875
Clennon EK, Pare E, Amato P, Caughey AB. Use of gestational surrogates for women with Eisenmenger syndrome: a cost-effectiveness analysis. J Matern Fetal Neonatal Med. 2021;34(4):526–31.
doi: 10.1080/14767058.2019.1610734 pubmed: 31006283
Sliwa K, Baris L, Sinning C, et al. Pregnant women with uncorrected congenital heart disease: heart failure and mortality. JACC Heart Fail. 2020;8(2):100–10.
doi: 10.1016/j.jchf.2019.09.001 pubmed: 31511192
Miao H, Chen Y, Wang C, Huang T, Lin J. Pregnancies in women with moderate and severe pulmonary hypertension remain challenging: a single-center experience in East China. Int J Gynaecol Obstet. 2021. https://doi.org/10.1002/ijgo.13708 .
doi: 10.1002/ijgo.13708 pubmed: 34498265
Ogawa A, Satoh T, Tamura Y, et al. Survival of Japanese patients with idiopathic/heritable pulmonary arterial hypertension. Am J Cardiol. 2017;119(9):1479–84.
doi: 10.1016/j.amjcard.2017.01.015 pubmed: 28267959
Maxwell A, Holman T, Novak T, et al. Idiopathic pulmonary arterial hypertension unmasked by pregnancy. Acute Med. 2020;19(4):240–3.
doi: 10.52964/AMJA.0833 pubmed: 33215178
Paciocco G, Lombi A, Vincenzi A, et al. Right ventricular reverse remodelling in idiopathic pulmonary arterial hypertension diagnosed during pregnancy: is it possible? Respir Med Case Rep. 2016;24(20):59–60.
Yuan SM. Eisenmenger Syndrome in Pregnancy. Braz J Cardiovasc Surg. 2016;31(4):325–9.
pubmed: 27849306 pmcid: 5094422
Rex S, Devroe S. Anesthesia for pregnant women with pulmonary hypertension. Curr Opin Anaesthesiol. 2016;29(3):273–81.
doi: 10.1097/ACO.0000000000000310 pubmed: 26978591
Wang J, Jiakai Lu. Anesthesia for pregnant women with pulmonary hypertension. J Cardiothorac Vasc Anesth. 2020;S1053–0770(20):30604–12.
Galiè N, Humbert M, Vachiery JL, et al, ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al, ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241.
McLaughlin VV, Shah SJ, Souza R, Humbert M. Management of pulmonary arterial hypertension. J Am Coll Cardiol. 2015;65(18):1976–97.
doi: 10.1016/j.jacc.2015.03.540 pubmed: 25953750
Konstantinides SV. Trends in pregnancy outcomes in patients with pulmonary hypertension: still a long way to go. Eur J Heart Fail. 2016;18:1129–31.
doi: 10.1002/ejhf.616 pubmed: 27594175
Greutmann M, Pieper PG. Pregnancy in women with congenital heart disease. Eur Heart J. 2015;36:2491–9.
doi: 10.1093/eurheartj/ehv288 pubmed: 26112887
Cauldwell M, Dos Santos F, Steer PJ, Swan L, Gatzoulis M, Johnson MR. Pregnancy in women with congenital heart disease. BMJ. 2018;360:k478.
doi: 10.1136/bmj.k478 pubmed: 29523513

Auteurs

Yang Liu (Y)

Department of Pediatric Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.

Haitao Li (H)

Department of Adult Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.

Yanna Li (Y)

Department of Obstetrics and Gynecology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.

Jun Zhang (J)

Department of Obstetrics and Gynecology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.

Hong Gu (H)

Department of Pediatric Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China.

Jiangang Wang (J)

Department of Adult Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China. jiangangwang@ccmu.edu.cn.
Capital Medical University, Beijing Anzhen Hospital, No.2 An Zhen Road, Chaoyang District, Beijing, 100029, China. jiangangwang@ccmu.edu.cn.

Qiang Wang (Q)

Department of Pediatric Cardiac Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Chaoyang District, Beijing, China. wq.cory@163.com.
Capital Medical University, Beijing Anzhen Hospital, No.2 An Zhen Road, Chaoyang District, Beijing, 100029, China. wq.cory@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH